The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year

FDA Knew Drugmaker Had Poor Record. It Waited Four Years to Inspect One Factory.

A Glenmark Pharmaceuticals factory in central India had been producing a generic drug linked to U.S. deaths.

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.